Research study Program year 2021 Source: CMS Open Payments

Ph2b In Subjects with SLE

Research payments

$1,020,563

89 payments

Through program year 2021, $1,020,563 in research payments was reported against Ph2b In Subjects with SLE, across 89 payments, paid by Amgen Inc..

Paid by: Amgen Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

1 row

Year	Kind	Amount	Payments
2021	Research	$1,020,563	89

Breakdown

Who paid Research payments · program year 2021

Amgen Inc. $1,020,563 89 payments

Who received the money Research payments · program year 2021

Ramesh Gupta Memphis, TN $101,514 2 payments
Arizona Arthritis And Rheumatology Associates Pc Organisation paid for research $79,904 6 payments
Life Clinical Trials Organisation paid for research $66,672 2 payments
Crisalis LLC Organisation paid for research $59,000 1 payment
Arthritis And Rheumatic Disease Specialties Organisation paid for research $50,339 2 payments
Clinical Trials Of Texas Organisation paid for research $47,922 2 payments
Clinic Of Robert Hozman, MD - Clinical Investigational Specialists, INC Organisation paid for research $47,254 2 payments
Feinstein Institute for Medical Research Organisation paid for research $41,901 2 payments
Djl Clinical Research Pllc Organisation paid for research $38,182 2 payments
Precision Comprehensive Clinical Research Solutions Organisation paid for research $34,768 2 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.